Search - tctmd.com

Displaying 21 - 33 of 33

Sort: Relevancy | Date

News Conference News ESC 2021

IAMI: Influenza Vaccine Beneficial for Post-MI Patients

Michael O'Riordan

August 30, 2021

News Opinion Editor's Corner ESC 2021

ESC 2021: Trials, Guidelines, and Channel Surfing at This Year’s Virtual Congress

Shelley Wood

August 19, 2021

News Daily News

High Glycemic Index Diets Linked to CVD and Mortality

Michael O'Riordan

February 24, 2021

News Daily News

Women’s Risk for CVD Seen at Lower BP Thresholds Than Men

L.A. McKeown

February 24, 2021

News Conference News ESC 2020

EXPLORER-HCM: Mavacamten Improves Exercise Capacity and Functional Class

Michael O'Riordan

August 29, 2020

News Daily News

Higher Risk of HF After ACS for Women Previously on Beta-blockers

Michael O'Riordan

July 16, 2020

News Daily News

TAVR and Other Advanced CVD Therapies Used Less in Ontario Than NY State

Michael O'Riordan

January 22, 2020

News Conference News ACC 2019

New DECLARE-TIMI 58 Data Shine a Light on Diabetes Patients Most Likely to Benefit From Dapagliflozin

Shelley Wood

March 26, 2019

News Daily News

Surviving CVD: Obesity Offers No Protection for Those With New Onset Cardiac Events

Michael O'Riordan

December 07, 2017

News Daily News

New Heart Failure Cases Rising Among Older Adults, MI Survivors

L.A. McKeown

November 24, 2017

News Conference News ACC 2017

Erectile Dysfunction Meds Linked to Fewer Death and HF Hospitalizations After MI

L.A. McKeown

March 09, 2017

News Industry News

Juventas Therapeutics Presents New 12-Month Data Demonstrating Single Administration of JVS-100 Improves Cardiac and Clinical Status in Patients with Severe Ischemic Heart Failure One Year After Treat

May 26, 2015

News Industry News

CVRx® Barostim Therapy® for Heart Failure Clinical Trial Results Presented in the Late-Breaking Clinical Trial Session of the Heart Rhythm Society 2015 Annual Conference

May 26, 2015

Advertisement

IAMI: Influenza Vaccine Beneficial for Post-MI Patients

ESC 2021: Trials, Guidelines, and Channel Surfing at This Year’s Virtual Congress

High Glycemic Index Diets Linked to CVD and Mortality

Women’s Risk for CVD Seen at Lower BP Thresholds Than Men

EXPLORER-HCM: Mavacamten Improves Exercise Capacity and Functional Class

Higher Risk of HF After ACS for Women Previously on Beta-blockers

TAVR and Other Advanced CVD Therapies Used Less in Ontario Than NY State

New DECLARE-TIMI 58 Data Shine a Light on Diabetes Patients Most Likely to Benefit From Dapagliflozin

Surviving CVD: Obesity Offers No Protection for Those With New Onset Cardiac Events

New Heart Failure Cases Rising Among Older Adults, MI Survivors

Erectile Dysfunction Meds Linked to Fewer Death and HF Hospitalizations After MI

Juventas Therapeutics Presents New 12-Month Data Demonstrating Single Administration of JVS-100 Improves Cardiac and Clinical Status in Patients with Severe Ischemic Heart Failure One Year After Treat

CVRx® Barostim Therapy® for Heart Failure Clinical Trial Results Presented in the Late-Breaking Clinical Trial Session of the Heart Rhythm Society 2015 Annual Conference

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content